Safety and efficacy of 3-month dual antiplatelet therapy after drug-eluting stents: a network bayesan meta-analysis of randomised clinical trials

Back

ESC Premium Access

Safety and efficacy of 3-month dual antiplatelet therapy after drug-eluting stents: a network bayesan meta-analysis of randomised clinical trials

Session: Poster Session 5 - Interventional cardiology - General aspects

Topic: Adjunctive Pharmacotherapy

Speaker: Doctor G. Ferrante (Milan, IT)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Giuseppe Ferrante

Humanitas University, Milan (Italy)

0 follower

11 more presentations in this session

Women in medicine: addressing the gender gap in interventional cardiology in Australia and New Zealand

Speaker: Doctor S. Burgess (Sydney, AU)

Access

Abstract

Slides

Predictors for angiographic edge restenosis of 2nd generation drug-eluting stents: Integrated angiographic analyses from the post-marketing surveillance studies of everolimus-eluting stents in Japan

Speaker: Professor K. Kozuma (Tokyo, JP)

Access

Abstract

Slides

Do women benefit from bilateral internal mammary artery bypass grafting?

Speaker: Miss F. Saraiva (Porto, PT)

Access

Abstract

Utilizing telemedicine platforms to construct population-based AMI management - Results from half a million patient encounters in Latin America Telemedicine Infarct Network (LATIN)

Speaker: Doctor S. Mehta (Miami, US)

Access

Abstract

Slides

Duration of dual anti platelet therapy in elective drug coated balloon angioplasty

Speaker: Doctor N. Corballis (Norwich, GB)

Access

Abstract

Slides

Access the full session

Poster Session 5 - Interventional cardiology - General aspects

Speakers: Doctor G. Ferrante, Doctor S. Burgess, Professor K. Kozuma, Miss F. Saraiva, Doctor S. Mehta...

Access

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources